GLP-1 Users Are Reporting Their Fingernails Detaching

Key Points:

• A study of 1,904 people across four countries found that nail detachment was reported by 39% of GLP-1 drug users, compared to 9% of people with type 2 diabetes or obesity who had never taken these medications, though about half of users had nail problems before treatment.
• Nail discoloration and other nail disorders were also more common among GLP-1 users, with 66% reporting at least one nail issue versus 53% of controls, but the study's cross-sectional design and reliance on self-reported symptoms mean it cannot confirm causation.
• A companion study on the same participants found higher rates of unusual hair loss and scalp symptoms among GLP-1 users, suggesting possible inflammation-related effects beyond typical shedding after weight loss.
• The research did not specify which GLP-1 drugs were involved or differentiate between types of nail detachment, and the findings have yet to be published in a peer-reviewed journal.
• Researchers plan to conduct longitudinal studies with standardized examinations to better understand the timing, causes, and reversibility of these nail and hair changes, advising patients to consult doctors about symptoms rather than stopping treatment abruptly.